Skip to main content
. Author manuscript; available in PMC: 2021 Dec 7.
Published in final edited form as: Am J Obstet Gynecol. 2019 Jun 4;221(4):337.e1–337.e5. doi: 10.1016/j.ajog.2019.05.035

TABLE 2.

Maternal outcomes in the 2 study groups

Outcomes ePAS (n = 189) uPAS (n = 54) Pvalue
Primary
 RBC units transfused, median [IOR] 2 [0–5] 4 [1–6] .03a
Secondary
 EBL, L, median [IOR] 1.7 [1.2–3.0] 2.4 [1.4–3.0] .04a
Other
 Platelet units transfused, median [IOR] 0 [0–0] 0 [0–1] .01a
 FFP units transfused, median [IQR] 0 [0–2] 0 [0–4] .19
 Crystalloid infusion, L, median [IQR] 3.6 [2.8–4.5] 3.5 [2.8–4.5] .74
 Length of hospital stay, days, median [IQR] 5 [4–7] 4 [3–6] .02a
Reoperation, n, % 4 (2.1) 1 (1.8) .99
Readmission, n, % 3 (1.6) 4 (7.4) .04a
Unintentional cystotomy, n, % 7 (3.7) 2 (3.7) .99
Vesicouterine fistula, n, % 2 (1.1) 0 .99
Acute kidney injury, n, % 0 0
DVT or PE, n, % 0 0
DIC, n, % 22 (11.6) 5 (9.3) .62
Maternal death, n, % 1 (05) 1 (1.8) .40

DIC is calculated as per the definition of the International Society of Thrombosis and Homeostasis. Variables are reported as median [IQR] (Mann-Whitney U test) and n (percentage) (χ2/Fisher exact test).

DIC, disseminated intravascular coagulation; DVT, deep vein thrombosis; EBL, estimated blood loss; FFP, fresh-frozen plasma; ICU, intensive care unit; PAS, placenta accreta spectrum; PE, pulmonary embolism; RBC, red blood cell.

a

Statistically significant.

Erfani et al. Unexpected placenta accreta spectrum (PAS). Am J Obstet Gynecol 2019.